Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Conference Coverage (AACR)
Attenuated Salmonella typhimurium Targets Cancer Cells
May 26th, 1997
An attenuated form of Salmonella typhimurium preferentially accumulates in and kills tumor cells. A collaborative effort between researchers from Vion Pharmaceuticals, Connecticut, and Yale University School of Medicine, Connecticut, has resulted in several studies (see subsequent stories in this issue) regarding an attenuated form of S. typhimurium as an anticancer agent. L.M. Zheng, representing colleagues from both institutions, presented evidence American Association for Cancer Research conference, held April 12-16, 1997, in San Diego, California that S. typhimurium infection inhibits tumor metastasis in vivo. ...
Source: Cancer Weekly (1997-05-26)
|
